November 20, 2026 · British journal of anaesthesia · DOI: 10.1016/j.bja.2026.10.007

Preoperative roxadustat in major elective noncardiac surgery: a phase 2a randomised clinical trial.

Listen to this summary

This phase 2a randomised pilot trial asked whether preoperative roxadustat, a prolyl hydroxylase inhibitor with experimental organ-protective and wound-healing effects, is tolerable and free of harmful surgical interactions in patients undergoing major elective noncardiac surgery. In 148 patients, preoperative adverse events occurred at similar rates with roxadustat (28%) and placebo (27%), with no serious adverse reactions, and postoperative complications were also similar (31% vs 30%). The authors conclude that preoperative roxadustat is feasible to deliver, but its safety and efficacy remain uncertain and require larger trials.

Andrew Toner, Tomas Corcoran, Damien Foo, Natalie Hird, Florencia Arteaga Galich, Simon Keely, Steve Webb, Cormac Taylor

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play